NICE Assessment Outcomes | Untied Kingdom | Drug News | Updates | 2024 | iPharmaCenter
top of page
January 10, 2024 NICE recommended Alexion's Kanuma for LAL deficiency Sebelipase alfa, marketed as Kanuma by Alexion, holds an indication...
HAS Assessment Outcomes | 2024 | France | Healthcare | Pharma | News | iPharmaCenter
January 08, 2024 ELFABRIO (pegunigalsidase alfa) - Unfavorable Reimbursement Opinion for Fabry Disease The reimbursement outlook for...
Germany healthcare news | 2023 | Bundestag reforms | Digital Health | iPharmaCenter
September 29, 2023 The German government commission urges stable financing for child and adolescent medicine, pediatric outpatient...
NICE Assessment outcomes (3/n) Bimzelx recommended for psoriatic arthritis | iPharmaCenter
November 15, 2023 NICE not recommended Pluvicto for PSMA-positive hormone-relapsed metastatic prostate cancer Lutetium-177 vipivotide...
NICE ASSESSMENT OUTCOMES | 2023 | (2/N) | UK HEALTHCARE NEWS | IPHARMACENTER
Camzyos (mavacamten) has been recommended as a viable option for treating symptomatic obstructive hypertrophic cardiomyopathy (oHCM) in...
NICE ASSESSMENT OUTCOMES | 2023 (1/N) United Kingdom | Healthcare | Pharma | News | iPharmaCenter
Yescarta has been recommended for adults with diffuse large B-cell lymphoma (DLBCL) after one treatment and is currently indicated as the...
HAS ASSESSMENT OUTCOMES | FRANCE PHARMA NEWS | médicament nouvelles | 2023 | iPharmaCenter
Find the latest healthcare and pharmaceutical news of France | HAS assessment outcomes and drug approvals in France of 2023
NICE ASSESSMENT OUTCOMES | 2022 United Kingdom | Healthcare | Pharma | News | Blogs | iPharm
December 15, 2022 SOBI's Doptelet was recommended for treating refractory primary chronic immune thrombocytopenia. NICE recommended using...
NHS England News | NHS to offer Tagrisso for lung cancer patients
NHS to offer Tagrisso for lung cancer patients NHS England announced that it would roll out Tagrisso (osimertinib) for lung cancer...
bottom of page